Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Page 1
Emergency Department Risk Factors for Post-Concussion Syndrome After Mild Traumatic Brain Injury: A Systematic Review.
Lubbers VF, van den Hoven DJ, van der Naalt J, Jellema K, van den Brand C, Backus B. Lubbers VF, et al. Among authors: jellema k. J Neurotrauma. 2024 Mar 13. doi: 10.1089/neu.2023.0302. Online ahead of print. J Neurotrauma. 2024. PMID: 38390830 Review.
Recent studies suggest that early treatment can greatly improve prognosis and prevent long-term effects in these patients. However, early recognition of patients at high risk of PCS remains difficult. ...
Recent studies suggest that early treatment can greatly improve prognosis and prevent long-term effects in these patients. However, e …
Ethnic disparities in long-term outcomes and health care usage after stroke in the Netherlands.
Lee YX, Auwerda ST, Jellema K, Vliet Vlieland TPM, Arwert HJ. Lee YX, et al. Among authors: jellema k. Disabil Health J. 2024 Jan 15:101582. doi: 10.1016/j.dhjo.2024.101582. Online ahead of print. Disabil Health J. 2024. PMID: 38246799
BACKGROUND: Poststroke health-related quality of life (HRQOL) is an important outcome that may be influenced by ethnicity. OBJECTIVE: To compare long-term HRQOL, mental health and healthcare utilization between stroke survivors with a European (EUB) and non-European backgr …
BACKGROUND: Poststroke health-related quality of life (HRQOL) is an important outcome that may be influenced by ethnicity. OBJECTIVE: To com …
The cognitive status of chronic subdural hematoma patients after treatment: an exploratory study.
Blaauw J, Hertog HMD, Holl DC, Thüss NS, van der Gaag NA, Jellema K, Dammers R, Kho KH, Groen RJM, Lingsma HF, Jacobs B, van der Naalt J. Blaauw J, et al. Among authors: jellema k. Acta Neurochir (Wien). 2023 Mar;165(3):701-709. doi: 10.1007/s00701-023-05508-7. Epub 2023 Feb 8. Acta Neurochir (Wien). 2023. PMID: 36752891 Free PMC article.
Cognitive impairment is frequently observed at presentation. However, the course and longer term aspects of the cognitive status of CSDH patients are unknown. ...
Cognitive impairment is frequently observed at presentation. However, the course and longer term aspects of the cognitive status of C …
Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial.
Tjerkstra MA, Post R, Germans MR, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, Van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, Bienfait HP, Boogaarts H, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWM, Vandertop WP, Verbaan D; ULTRA investigators. Tjerkstra MA, et al. Among authors: jellema k. Neurology. 2022 Dec 5;99(23):e2605-e2614. doi: 10.1212/WNL.0000000000201160. Neurology. 2022. PMID: 36266046 Clinical Trial.
BACKGROUND AND OBJECTIVES: The ULTRA trial showed that ultra-early and short-term tranexamic acid treatment after subarachnoid hemorrhage did not improve clinical outcome at 6 months. ...After confirmation of subarachnoid hemorrhage on noncontrast CT, patients were allocat …
BACKGROUND AND OBJECTIVES: The ULTRA trial showed that ultra-early and short-term tranexamic acid treatment after subarachnoid hemorr …
Mortality after chronic subdural hematoma is associated with frailty.
Blaauw J, Jacobs B, Hertog HMD, van der Gaag NA, Jellema K, Dammers R, Kho KH, Groen RJM, van der Naalt J, Lingsma HF. Blaauw J, et al. Among authors: jellema k. Acta Neurochir (Wien). 2022 Dec;164(12):3133-3141. doi: 10.1007/s00701-022-05373-w. Epub 2022 Sep 29. Acta Neurochir (Wien). 2022. PMID: 36173514 Free PMC article.
PURPOSE: Chronic subdural hematoma (CSDH) is a common neurological disease often affecting the elderly. Long-term excess mortality for patients after CSDH has been suggested but causes of death are unknown. ...
PURPOSE: Chronic subdural hematoma (CSDH) is a common neurological disease often affecting the elderly. Long-term excess mortality fo …
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, van de Vlekkert J, Bienfait HP, Boogaarts HD, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D; ULTRA Investigators. Post R, et al. Among authors: jellema k. Lancet. 2021 Jan 9;397(10269):112-118. doi: 10.1016/S0140-6736(20)32518-6. Epub 2020 Dec 23. Lancet. 2021. PMID: 33357465 Clinical Trial.
BACKGROUND: In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding. However, whether this treatment improves clinical outcome is unclear. We investigated whether ultra-e …
BACKGROUND: In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic therapy with tranexamic acid has been s …
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium. Jacobs BC, et al. J Peripher Nerv Syst. 2017 Jun;22(2):68-76. doi: 10.1111/jns.12209. J Peripher Nerv Syst. 2017. PMID: 28406555
The IGOS data/biobank is available for research projects conducted by expertise groups focusing on specific topics including epidemiology, diagnostic criteria, clinimetrics, electrophysiology, antecedent events, antibodies, genetics, prognostic modeling, treatment effects, and lo …
The IGOS data/biobank is available for research projects conducted by expertise groups focusing on specific topics including epidemiology, d …
Spinal dural arteriovenous fistulas: long-term follow-up of 44 treated patients.
Jellema K, Tijssen CC, van Rooij WJ, Sluzewski M, Koudstaal PJ, Algra A, van Gijn J. Jellema K, et al. Neurology. 2004 May 25;62(10):1839-41. doi: 10.1212/01.wnl.0000125322.76322.6e. Neurology. 2004. PMID: 15159489
To assess the long-term clinical course of 44 patients treated for a spinal dural arteriovenous fistula, patients were re-examined after a median follow-up of 5.7 years. ...
To assess the long-term clinical course of 44 patients treated for a spinal dural arteriovenous fistula, patients were re-examined af …